000 | 00984nam a2200253 a 4500 | ||
---|---|---|---|
008 | 101125s2008^^^^xxua^^^^^^^^^^000^0^eng^^ | ||
020 | _a9781420053562 (obra completa : papel alcalino) | ||
020 | _a1420053566 (obra completa : papel alcalino) | ||
035 | _aMX001001235145 | ||
040 |
_aDNLM/DLC _bspa _cDLC _dNLM _dBAKER _dBTCTA _dOCLCG _dC#P _dBWX _dYDXCP _dCDX _dIXA _dDLC _dUNAMX |
||
050 | 0 | 0 |
_aRS201.C64 _bM63 2008 |
082 | 0 | 0 |
_a615/.19 _222 |
245 | 0 | 0 |
_aModified-release drug delivery technology / _cedited by Michael J. Rathbone [y otros tres] |
250 | _a2nd ed. | ||
264 | 1 |
_aNew York : _bInforma Healthcare, _cc2008 |
|
300 |
_a2 volúmenes : _bilustraciones |
||
336 |
_atexto _2rdacontent |
||
337 |
_asin medio _2rdamedia |
||
338 |
_avolumen _2rdacarrier |
||
490 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 183-184 |
|
650 | 0 | _aEfecto retardado | |
650 | 0 | _aPreparados de acción prolongada | |
700 | 1 |
_aRathbone, Michael J., _d1957- , _eeditor |
|
999 |
_c2950 _d2950 |